Show
Sort by
-
ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells
-
Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics and DNA repair
-
SOX11 functions as an oncogene in Lmo2-driven T-cell lymphoblastic leukemia (T-ALL)
-
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells
-
Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
-
CAR-T treatment of pediatric AML : a long and winding road
-
Association of unbalanced translocation der(1;7) with germline GATA2 mutations
-
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
-
The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1
-
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma